These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33564404)

  • 21. Adult classic Bartter syndrome: a case report with 5-year follow-up and literature review.
    Jiang L; Li D; Guo Q; Li Y; Zan L; Ao R
    Endocr J; 2024 May; 71(5):537-542. PubMed ID: 38508775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bartter syndrome: unraveling the pathophysiologic enigma.
    Guay-Woodford LM
    Am J Med; 1998 Aug; 105(2):151-61. PubMed ID: 9727823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of Bartter syndrome in 54 patients: A multicenter study in Korea.
    Choi N; Kim SH; Bae EH; Yang EM; Lee KH; Lee SH; Lee JH; Ahn YH; Cheong HI; Kang HG; Hyun HS; Kim JH
    Front Med (Lausanne); 2023; 10():1099840. PubMed ID: 36993809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome: A Family Report.
    London S; Levine MA; Li D; Spiegel R; Lebel A; Halevy R; Tenenbaum-Rakover Y
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1679-e1688. PubMed ID: 34751387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome].
    Gitelman Syndrome Collaborative Study Group
    Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):712-716. PubMed ID: 28870047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bartter Syndrome: Perspectives of a Pediatric Nephrologist.
    Choi N; Kang HG
    Electrolyte Blood Press; 2022 Dec; 20(2):49-56. PubMed ID: 36688207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis.
    Akil I; Ozen S; Kandiloglu AR; Ersoy B
    Clin Exp Nephrol; 2010 Jun; 14(3):278-82. PubMed ID: 20127383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotyping of hypokalaemic salt-losing tubular disorders.
    Reinalter SC; Jeck N; Peters M; Seyberth HW
    Acta Physiol Scand; 2004 Aug; 181(4):513-21. PubMed ID: 15283765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bartter syndrome type 3 in an elderly complicated with adrenocorticotropin-deficiency.
    Tamagawa E; Inaba H; Ota T; Ariyasu H; Kawashima H; Wakasaki H; Furuta H; Nishi M; Nakao T; Kaito H; Iijima K; Nakanishi K; Yoshikawa N; Akamizu T
    Endocr J; 2014; 61(9):855-60. PubMed ID: 24965226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gitelman Syndrome and Hypertension: A Case Report.
    Shaukat H; Nadeem S; Abdullah F; Khan MMM; Rizvi SW
    Cureus; 2023 Sep; 15(9):e44590. PubMed ID: 37795074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Hypokalemic-Alkalotic Salt-Losing Tubulopathy in Patients with
    Bongers EMHF; Shelton LM; Milatz S; Verkaart S; Bech AP; Schoots J; Cornelissen EAM; Bleich M; Hoenderop JGJ; Wetzels JFM; Lugtenberg D; Nijenhuis T
    J Am Soc Nephrol; 2017 Oct; 28(10):3118-3128. PubMed ID: 28674042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gitelman syndrome combined with complete growth hormone deficiency.
    Min SR; Cho HS; Hong J; Cheong HI; Ahn SY
    Ann Pediatr Endocrinol Metab; 2013 Mar; 18(1):36-9. PubMed ID: 24904849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bartter Syndrome Presenting as Arginine-Vasopressin Resistance: A Report of 2 Cases.
    Sousa M; Medeiros R; Rodrigues AL; Dias Pereira B
    Am J Case Rep; 2024 Jun; 25():e942872. PubMed ID: 38885190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing.
    Stevenson M; Pagnamenta AT; Mack HG; Savige J; Giacopuzzi E; Lines KE; Taylor JC; Thakker RV
    J Endocr Soc; 2022 Jul; 6(7):bvac079. PubMed ID: 35668994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1.
    Adachi M; Asakura Y; Sato Y; Tajima T; Nakajima T; Yamamoto T; Fujieda K
    Endocr J; 2007 Dec; 54(6):1003-7. PubMed ID: 17998760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes.
    Zelikovic I; Szargel R; Hawash A; Labay V; Hatib I; Cohen N; Nakhoul F
    Kidney Int; 2003 Jan; 63(1):24-32. PubMed ID: 12472765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A thiazide test for the diagnosis of renal tubular hypokalemic disorders.
    Colussi G; Bettinelli A; Tedeschi S; De Ferrari ME; Syrén ML; Borsa N; Mattiello C; Casari G; Bianchetti MG
    Clin J Am Soc Nephrol; 2007 May; 2(3):454-60. PubMed ID: 17699451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of Bartter syndrome type I with atypical presentations.
    Lee EH; Heo JS; Lee HK; Han KH; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2010 Aug; 53(8):809-13. PubMed ID: 21189980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bartter-like Syndrome Induced By Tacrolimus in a Renal Transplanted Boy: A Case Report.
    Dias RF; da Costa Monteiro M; Silva RAM; Diniz MML; Simões E Silva AC
    Curr Drug Saf; 2023; 18(3):398-403. PubMed ID: 35593330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bartter syndrome type III and congenital anomalies of the kidney and urinary tract: an antenatal presentation.
    Westland R; Hack WW; van der Horst HJ; Uittenbogaard LB; van Hagen JM; van der Valk P; Kamsteeg EJ; van den Heuvel LP; van Wijk JA
    Clin Nephrol; 2012 Dec; 78(6):492-6. PubMed ID: 23164417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.